Lorenzo Corsini

TIME’s Best Inventions of 2023 list is out now, and the team at Equatic is so excited to be a part of it! time.com/collection/bes… #TIMEBestInventions #CDR #GreenHydrogen

Boeing signs alternative fuel deal with Los Angeles startup to cut carbon footprint washingtonpost.com/business/2023/…

We’ve built a climate solution that will power decarbonization at the scale, speed and cost necessary to combat climate change. Today we announce our work with @Boeing to remove 62,000 tonnes of carbon dioxide and deliver 2,100 metric tonnes of carbon-negative hydrogen.

"The ocean is already the planet’s most powerful carbon removal tool. But we need it to do more to reach net zero emissions." bloomberg.com/news/articles/… via @business

“If you want to remove carbon dioxide from the atmosphere one of the most effective ways to do it is by removing it from the oceans.” @gnsant forbes.com/sites/alanohns…

🏆 Congratulations to Jürgen Knoblich, Nina Corsini & @OEichmueller on the Alfred Hauptmann #Award for their work on Tuberous Sclerosis! @Knoblich_lab ➡️ bit.ly/HauptmannPrize… Awarded today by the 🇩🇪,🇦🇹 &🇨🇭 Societies for #Epilepsy Research @oeaw @viennabiocenter @MedUni_Wien

We are hiring multiple roles at #biontech R&D Austria (Vienna). Interested in developing (Ribo-)Lysins for the treatment of persistent and biofilm-related bacterial infections? Expert Protein Expr&Purif, Research Associate, Lab Technician, Expert Bioinfo jobs.biontech.com/search/?create…

Interested in applying protein engineering to solving the #antimicrobialresistance crisis? Join us as Expert Bioinformatics at #BioNTech R&D Austria to develop #ribolysins #endolysins #lysins jobs.biontech.com/job/Wien-Exper…

We are preparing PM-477 for clinical trials - stay tuned! @phagomed @AlexBelcredi #bacterialvaginosis #bvresearch #sexualhealth #endolysins #amr #antibacterial

The failure of MDZ and CLI with respect to resistance formation and biofilm activity, respectively, may partially explain the high recurrence rates seen for bacterial vaginosis. Particularly for women with a history of BV, these results may explain the low efficacy of treatment.

Recurrent #bacterialvaginosis: check out our latest paper on the in vitro comparison of PM-477 with the standard of care antibiotics #metronidazole (MDZ) and #clindamycin (CLI): journals.asm.org/doi/full/10.11…

Interested in revolutionizing antimicrobial therapy? Join us as Director Discovery at BioNTech R&D Austria! Unique next step opportunity for experienced drug developer or R&D leader from biotech or academia. jobs.biontech.de/Director-Disco… #amr #endolysins #drugdiscovery #biotech

Microbiologists and protein scientists wanted - join us to work on the next frontier of antimicrobials!

@structplantbio Now I also saw that it’s a 5-ring, didn’t look at electron densities for many years. But what’s even more interesting is that this program (was it called Coot?) still looks exactly the same as it did 13-14 years ago when you showed me how to use it :-)

@structplantbio Nitropyridine

@AlexanderStark8 This is really promising. If you find a way to implement it in one country/region, every politician elsewhere will want it too

wow, this is crazy. however, when we offered to discuss if and how SARSeq could be use to increase testing at much lower costs, there was no interest from the ministry 😕 medrxiv.org/content/10.110…

I‘m sure there is a way to implement this, in Austria or elsewhere, to save lives and avoid continuously repeated lockdowns